Publications by authors named "Carsten Zwick"

Claim this Profile
O
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Marita Ziepert, M Loeffler, Carsten Zwick

Br J Haematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Frank Neumann, Michael Pfreundschuh, Klaus D Preuss, Claudia Schormann, Carsten Zwick

Int J Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group.
Michael Pfreundschuh, Viola Poeschel, Samira Zeynalova, Mathias Hänel, Gerhard Held, Carsten Zwick

J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.
Carsten Zwick, Gerhard Held, Michaela Auth, Leon Bernal-Mizrachi, John D Roback

Int J Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas.
Niels Murawski, Gerhard Held, Marita Ziepert, Barbara Kempf, Andreas Viardot, Carsten Zwick

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma.
Gerhard Held, Niels Murawski, Marita Ziepert, Jochen Fleckenstein, Viola Pöschel, Carsten Zwick

J Clin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal dosing of rituximab in male and female patients with DLBCL.
Michael Pfreundschuh, Carsten Müller, Samira Zeynalova, Evelyn Kuhnt, Martin H J Wiesen, Carsten Zwick

Blood· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL.
Karin Hohloch, Carsten Zwick, Marita Ziepert, Dirk Hasenclever, Ulrich Kaiser

Springerplus· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement.
Gerhard Held, Samira Zeynalova, Niels Murawski, Marita Ziepert, Barbara Kempf, Carsten Zwick

J Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors.
Frank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, Klaus-Dieter Preuss, Gerhard Held, Carsten Zwick

Cancer Immunol Immunother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells.
Carsten Zwick, Natalie Fadle, Evi Regitz, Maria Kemele, Stephan Stilgenbauer

Blood· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trial.
Boris Kubuschok, Michael Pfreundschuh, Rainer Breit, Frank Hartmann, Martina Sester, Carsten Zwick

Hum Gene Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fourteen-day rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP-14): use it right or do not use it at all.
Carsten Zwick, Michael Pfreundschuh

Leuk Lymphoma· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Carsten Müller, Niels Murawski, Martin H J Wiesen, Gerhard Held, Viola Poeschel, Carsten Zwick

Blood· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in high-grade lymphoma.
Carsten Zwick, Niels Murawski, Michael Pfreundschuh,

Semin Hematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresolved issues in diffuse large B-cell lymphomas.
Niels Murawski, Carsten Zwick, Michael Pfreundschuh

Expert Rev Anticancer Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens.
Carsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, Gerhard Held, Manfred Ahlgrimm

Ann Hematol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas.
Carsten Zwick, Gerhard Held, Vera Hammermeister, Adnan Alahmad, Boris Kubuschok

J Cancer Res Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Carsten Zwick, Josef Birkmann, Norma Peter, Heinrich Bodenstein, Roland Fuchs

Ann Hematol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma.
Carsten Zwick, Beate Gleissner, Michael Pfreundschuh

Clin Lymphoma Myeloma· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.
Gerhard Held, Andreas Wadle, Nina Dauth, Guillaume Stewart-Jones, Christine Sturm, Carsten Zwick

Eur J Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological immune response to cancer testis antigens in patients with pancreatic cancer.
Andreas Wadle, Boris Kubuschok, Jochen Imig, Beate Wuellner, Christine Wittig, Carsten Zwick

Int J Cancer· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Klaus-Dieter Preuss, Carsten Zwick, Claudia Bormann, Frank Neumann, Michael Pfreundschuh

Immunol Rev· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.
Ozlem Türeci, Ugur Sahin, Michael Koslowski, Benedikt Buss, Carolin Bell, Carsten Zwick

Oncogene· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis